SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-09-02
👔
Vaxcyte, Inc.
@PCVX_InsiderForm 4 Filing: GUGGENHIME ANDREW Surrenders for Taxes $166K of $PCVX
TAX WITHHOLDING
⚡ MATERIALITY: 4/10
corporate issuer
Vaxcyte, Inc.
Ticker: $PCVX
Transaction Value
$166K
Price/Share: $61.18
transaction date
2026-09-02
Shares: 2,705
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, GUGGENHIME ANDREW, holds the title of PRESIDENT AND CFO at Vaxcyte, Inc..
On 2026-09-02, the insider transacted 2,705 shares.The shares were transacted at a weighted average price of $61.18 per share, resulting in a total market-relevant value of $166K.
Executive Summary Summary
GUGGENHIME ANDREW (PRESIDENT AND CFO) had withheld for taxes $166K of $PCVX
Post-Transaction Position: 102,471 shares
SEC Accession No: 0001230724-26-000016 (CIK: 1230724)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.